v3 Template
V

Vicebio

Biotechnology ~380 employees
Founded
--
Employees (Est.)
~380
19 leaders known
Total Funding
$100.0M
Funding Rounds
1
Last Funding
2024-09-23

About Vicebio

Vicebio is a biotech company focused on redefining respiratory disease prevention. They leverage groundbreaking Molecular Clamp technology to develop next-generation vaccines that offer broad protection, ready-to-use formulations, and high manufacturability, aiming to address pressing global health challenges with a robust pipeline.

Products & Services

Next-Generation Vaccines:Vaccines developed using Molecular Clamp technology for broad protection against respiratory diseases with ready-to-use formulations and high manufacturability.
Multipathogen Respiratory Vaccines:A pipeline focused on leading vaccines targeting multiple respiratory pathogens, including RSV and hMPV.

Specialties

Respiratory Disease Prevention Molecular Clamp Technology Vaccine Innovation Multipathogen Vaccines

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Series B
T: -
FT: Series B 		A: 100000000
MR: -
FA: $100 million
FAN: 100000000 		D: 2024-09-23
FD: 2024-09-23 		6 investors
Series B Latest
2024-09-23
$100.0M
6 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

E

Emmanuel Hanon

Chief Executive Officer

LinkedIn (Pro only)
K

Keith Chappell

Lead Scientific Advisor

LinkedIn (Pro only)
G

Giovanni Della Cioppa

Chief Medical Advisor

LinkedIn (Pro only)
J

Jean Smal

Chief Technology Officer

J

Juana Magdalena

Chief Development Officer

P

Pascal Lestrate

Chief Preclinical Science Officer

View 16 more team members with Pro

Unlock Full Team Directory

Recent News

Vicebio Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology
Company Size
~380 employees (est.)

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro